Compare SGC & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGC | NYXH |
|---|---|---|
| Founded | 1920 | 2009 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Apparel | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.8M | 161.9M |
| IPO Year | 1994 | 2021 |
| Metric | SGC | NYXH |
|---|---|---|
| Price | $12.75 | $1.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $16.00 | $9.33 |
| AVG Volume (30 Days) | 54.8K | ★ 378.9K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.93% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $566,184,000.00 | N/A |
| Revenue This Year | $3.23 | $213.98 |
| Revenue Next Year | $3.82 | $126.25 |
| P/E Ratio | $216.83 | ★ N/A |
| Revenue Growth | ★ 0.09 | N/A |
| 52 Week Low | $8.30 | $1.26 |
| 52 Week High | $14.59 | $8.59 |
| Indicator | SGC | NYXH |
|---|---|---|
| Relative Strength Index (RSI) | 48.23 | 37.75 |
| Support Level | $9.38 | $1.26 |
| Resistance Level | $14.59 | $1.70 |
| Average True Range (ATR) | 0.77 | 0.12 |
| MACD | -0.10 | 0.06 |
| Stochastic Oscillator | 56.65 | 42.86 |
Superior Group Of Companies Inc designs apparel products. The company operates through three segments: i) The Branded Products segment, under the brands BAMKO and HPI, produces and sells customized merchandising solutions, promotional products, and branded uniform programs. ii) The Healthcare Apparel segment, under the brands Wink and Fashion Seal Healthcare, manufactures and sells healthcare apparel including scrubs, lab coats, protective apparel, and patient garments. iii) The Contact Centers segment, through The Office Gurus entities, provides outsourced, nearshore, and onshore business process outsourcing (BPO), contact center, and call-center support services to customers in North America. The majority of the company's revenue is derived from the Branded Products segment.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.